Dynavax Technologies Co. (NASDAQ:DVAX – Get Free Report) CAO Justin Burgess sold 8,061 shares of the company’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $14.54, for a total transaction of $117,206.94. The transaction was disclosed in a legal filing with the SEC, which is accessible […]
Dynavax Technologies Co. (NASDAQ:DVAX – Get Free Report) Director Andrew A. F. Hack sold 1,500,000 shares of Dynavax Technologies stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $14.39, for a total value of $21,585,000.00. Following the completion of the transaction, the director now directly owns 915,000 […]
Dynavax Technologies (NASDAQ:DVAX – Free Report) had its target price upped by JMP Securities from $24.00 to $25.00 in a report published on Friday morning, MarketBeat Ratings reports. They currently have an outperform rating on the biopharmaceutical company’s stock. Separately, StockNews.com initiated coverage on shares of Dynavax Technologies in a research report on Thursday, May […]
Dynavax Technologies Co. (NASDAQ:DVAX – Get Free Report) CAO Justin Burgess sold 8,061 shares of the business’s stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $14.54, for a total transaction of $117,206.94. The transaction was disclosed in a document filed with the SEC, which is available […]
Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84. The post Dynavax Technologies Stock…